Biocat to hold workshop to drive internationalization in Brazil
Featuring Eduardo Emrich Soares, president and CEO of Biominas in Belo Horizonte, which is home to the main biotechnology hub in Latin America.
By Biocat
Biocat, under the framework of the European bioXclusters project, is holding a workshop entitled Fostering internationalisation (I): Brazil on 17 April 2012 in Barcelona. This workshop is part of a series of three events that will be held in 2012 and 2013, which will invite experts to discuss different aspects of internationalization in the target markets: Brazil, China and the United States. This series aims to strengthen and promote the international competitiveness of Catalan biotechnology and biomedical firms in these countries, which are highly interesting due to the market opportunities they offer. The workshops, thus, will be geared towards executives and business development heads at SMEs from the biotechnology and biomedicine sector, as well as related research organizations and support bodies.
The workshop will be inaugurated by Adela Farré, Communications & External Relacions Director of Biocat. The first session will feature Eduardo Emrich Soares, president and CEO of Biominas. Biominas is an organization located in Belo Horizonte that focuses on promoting the biomedicine sector by strengthening the business fabric. A large part of private industry in the sector is found in the states of São Paulo (40.5%) and Minas Gerais (24.5%), specifically in the city of Belo Horizonte, which has the largest biotechnology cluster in South America. Speakers will include Trinitat Bofarull, Head of American Markets of ACC1Ó; Clara Nascimento, South America Business Unit Manager of Trifermed, and Eduardo Emrich Soares.
With more than 191 million inhabitants, Brazil is the largest market in Latin America and is a consolidated power in many sectors and emerging in others. With regard to the biotechnology arena, this country has a considerable industry related to the sector and a great research capacity, in addition to being a significant potential market for companies in other countries.
Both the regional and federal governments are actively promoting this sector through specific laws and numerous support programs. The most important subsectors are human (39.7%) and animal health (14.3%), the environment and bioenergy (14.8%) and agrobiotechnology (9.7%).
The biotech sector in Brazil has more than 237 companies, most of which (63%) were founded after 2000 and are micro or small companies.
Date: 17 April 2012
Time: 9 am to 2 pm
Venue: Palau Robert • Sala Cotxeres • Passeig de Gràcia, 107 • Barcelona (map)
The workshop will be given in English.
Registration closed.
Questions: events@biocat.cat
You can also follow on Twitter @bioXclusters
Related information:
- Reports about biotech sector in Brazil
- Article: The attractive Brazilian biomedical and biotechnological market (Eduardo Soares, May 2012)
- News: Biocat trade mission to learn about the biotech sector in Brazil (13/6/2012)
- News: Brazil, the complexities of a market full of opportunities (27/4/2012)
See all the news on the bioXclusters project.
Organizers:
